
### [NCIT:C2921](http://purl.obolibrary.org/obo/NCIT_C2921)
**Label:** Skin Basal Cell Carcinoma

**Subclasses:** [NCIT:C5568](http://purl.obolibrary.org/obo/NCIT_C5568) (Skin Nodulo-Ulcerative Basal Cell Carcinoma), [NCIT:C27539](http://purl.obolibrary.org/obo/NCIT_C27539) (Skin Infiltrating Basal Cell Carcinoma), [NCIT:C8014](http://purl.obolibrary.org/obo/NCIT_C8014) (Lip Basal Cell Carcinoma), [NCIT:C8213](http://purl.obolibrary.org/obo/NCIT_C8213) (Recurrent Lip Basal Cell Carcinoma), [NCIT:C27535](http://purl.obolibrary.org/obo/NCIT_C27535) (Skin Adenoid Basal Cell Carcinoma), [NCIT:C8197](http://purl.obolibrary.org/obo/NCIT_C8197) (Stage I Lip Basal Cell Carcinoma), [NCIT:C27537](http://purl.obolibrary.org/obo/NCIT_C27537) (Skin Cystic Basal Cell Carcinoma), [NCIT:C27536](http://purl.obolibrary.org/obo/NCIT_C27536) (Skin Clear Cell Basal Cell Carcinoma), [NCIT:C6082](http://purl.obolibrary.org/obo/NCIT_C6082) (External Ear Basal Cell Carcinoma), [NCIT:C6381](http://purl.obolibrary.org/obo/NCIT_C6381) (Vulvar Basal Cell Carcinoma), [NCIT:C27182](http://purl.obolibrary.org/obo/NCIT_C27182) (Skin Morphea-Type (Sclerosing) Basal Cell Carcinoma), [NCIT:C38109](http://purl.obolibrary.org/obo/NCIT_C38109) (Skin Basal Cell Carcinoma with Adnexal Differentiation), [NCIT:C8209](http://purl.obolibrary.org/obo/NCIT_C8209) (Stage IV Lip Basal Cell Carcinoma), [NCIT:C5616](http://purl.obolibrary.org/obo/NCIT_C5616) (Skin Nodular Solid Basal Cell Carcinoma), [NCIT:C54665](http://purl.obolibrary.org/obo/NCIT_C54665) (Skin Keratotic Basal Cell Carcinoma), [NCIT:C8205](http://purl.obolibrary.org/obo/NCIT_C8205) (Stage III Lip Basal Cell Carcinoma), [NCIT:C4346](http://purl.obolibrary.org/obo/NCIT_C4346) (Skin Basal Cell Carcinoma with Sebaceous Differentiation), [NCIT:C9359](http://purl.obolibrary.org/obo/NCIT_C9359) (Skin Pigmented Basal Cell Carcinoma), [NCIT:C8201](http://purl.obolibrary.org/obo/NCIT_C8201) (Stage II Lip Basal Cell Carcinoma), [NCIT:C5893](http://purl.obolibrary.org/obo/NCIT_C5893) (Stage 0 Lip Basal Cell Carcinoma AJCC v6 and v7), [NCIT:C7473](http://purl.obolibrary.org/obo/NCIT_C7473) (Anal Margin Basal Cell Carcinoma), [NCIT:C39961](http://purl.obolibrary.org/obo/NCIT_C39961) (Penile Basal Cell Carcinoma), [NCIT:C38110](http://purl.obolibrary.org/obo/NCIT_C38110) (Skin Signet Ring Cell Basal Cell Carcinoma), [NCIT:C38111](http://purl.obolibrary.org/obo/NCIT_C38111) (Skin Sarcomatoid Basal Cell Carcinoma), [NCIT:C62282](http://purl.obolibrary.org/obo/NCIT_C62282) (Skin Nodular Basal Cell Carcinoma), [NCIT:C2922](http://purl.obolibrary.org/obo/NCIT_C2922) (Skin Basosquamous Cell Carcinoma), 

**Class expressions from DL-Learner:**

- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C36777](http://purl.obolibrary.org/obo/NCIT_C36777) (Signet Ring Adenocarcinoma Cell))) 58.33%
- Thing 52.49%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39679](http://purl.obolibrary.org/obo/NCIT_C39679) (Hallmark Cell))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39674](http://purl.obolibrary.org/obo/NCIT_C39674) (Anaplastic Large Cell Lymphoma, Giant Cell Rich Subtype))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39657](http://purl.obolibrary.org/obo/NCIT_C39657) (Neoplastic T-Lymphocyte with Clear Cytoplasm))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39652](http://purl.obolibrary.org/obo/NCIT_C39652) (Proliferation of Follicular Dendritic Cells Present))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39651](http://purl.obolibrary.org/obo/NCIT_C39651) (Proliferation of High Endothelial Venules Present))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39646](http://purl.obolibrary.org/obo/NCIT_C39646) (Erythroderma))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39640](http://purl.obolibrary.org/obo/NCIT_C39640) (Mucinous Degeneration))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39629](http://purl.obolibrary.org/obo/NCIT_C39629) (CDKN2A Gene Inactivation))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39628](http://purl.obolibrary.org/obo/NCIT_C39628) (Single Cell Exocytosis))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39627](http://purl.obolibrary.org/obo/NCIT_C39627) (Pautrier Microabscess Present))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39626](http://purl.obolibrary.org/obo/NCIT_C39626) (Epidermotropic Lymphocytic Infiltrate))) 43.69%
- [NCIT:C12487](http://purl.obolibrary.org/obo/NCIT_C12487) (Signet Ring Cell) and (not ([NCIT:C39625](http://purl.obolibrary.org/obo/NCIT_C39625) (Extracutaneous Dissemination of Disease))) 43.69%


